Cargando…
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy
BACKGROUND: The need to promote novel drug development for advanced biliary tract cancer (ABTC) has emphasised the importance of determining whether various efficacy end points can act as surrogates for overall survival (OS). METHODS: We conducted a literature search of randomised trials of first-li...
Autores principales: | Moriwaki, Toshikazu, Yamamoto, Yoshiyuki, Gosho, Masahiko, Kobayashi, Mariko, Sugaya, Akinori, Yamada, Takeshi, Endo, Shinji, Hyodo, Ichinosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984805/ https://www.ncbi.nlm.nih.gov/pubmed/27031848 http://dx.doi.org/10.1038/bjc.2016.83 |
Ejemplares similares
-
Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
por: Moriwaki, Toshikazu, et al.
Publicado: (2021) -
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling
por: Wang, Xiaoxuan, et al.
Publicado: (2021) -
Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
por: Imanishi, Mamiko, et al.
Publicado: (2019) -
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression
por: Hamano, Yukako, et al.
Publicado: (2018) -
Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report
por: Yamaura, Masamichi, et al.
Publicado: (2018)